8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2021 / Prospective cohort study and meta-analysis of prospective cohort studies
Researchers analyzed 30,378 NHANES participants over a mean follow-up of 6.7 years and conducted a meta-analysis combining these data with four other prospective cohort studies (totaling 601,893 individuals). In NHANES, mushroom consumption showed a non-significant association with all-cause mortality after multivariable adjustments (adjusted HR 0.84; 95% CI: 0.67-1.06; 2,855 deaths). However, the meta-analysis found that mushroom consumption was associated with a lower risk of all-cause mortality (pooled risk ratio 0.94; 95% CI: 0.91, 0.98).
Shows an association, not proof of cause and effect.
Ba DM, Gao X, Al-Shaar L, et al. Nutr J, 2021. PMID 34548082
2020 / Randomized, double-blinded, placebo-controlled clinical trial
A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.
Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304
2016 / Retrospective analysis of a dietary intervention study
Researchers retrospectively analyzed data from 37 adults with metabolic syndrome who consumed 100 g of white button mushrooms daily for 16 weeks, followed by a one-month mushroom-free period. At 16 weeks, participants showed a doubling of serum ergothioneine, increases in ORAC and adiponectin, and significant decreases in carboxymethyllysine (CML) and methylglyoxal (MG). No changes were observed in 8-isoprostane, leptin, or measures of insulin resistance or glucose metabolism. The authors noted that well-controlled studies are needed to confirm these findings.
Calvo MS, Mehrotra A, Beelman RB, et al. Plant Foods Hum Nutr, 2016. PMID 27193019
2012 / Randomized controlled trial
Thirty-eight healthy adults were randomized to 4 groups consuming standard meals for 6 weeks: untreated mushrooms (control, 0.85 μg/d ergocalciferol), UV-treated mushrooms at 8.8 μg/d (M1) or 17.1 μg/d (M2), or purified ergocalciferol supplement plus untreated mushrooms (28.2 μg/d, S). At week 6, serum 25(OH)D2 increased by 1.2 ± 5.2 in C, 13.8 ± 7.3 in M1, 12.7 ± 3.7 in M2, and 32.8 ± 3.3 nmol/L in S. Concurrently, 25(OH)D3 decreased by -3.9 ± 16.3 in C, -10.4 ± 6.4 in M1, -20.6 ± 14.6 in M2, and -29.5 ± 15.9 nmol/L in S. Overall, ergocalciferol was absorbed and metabolized to 25(OH)D2 but did not affect overall vitamin D status because 25(OH)D3 decreased proportionally.
Stephensen CB, Zerofsky M, Burnett DJ, et al. J Nutr, 2012. PMID 22623385
2011 / 5-week, single-blinded, randomized, placebo-controlled trial
In a 5-week trial during winter, 26 young adults with serum 25OHD <= 50 nmol/l were randomized to receive 28,000 IU (700 ug) vitamin D2 via an experimental mushroom soup, 28,000 IU vitamin D2 via a supplement, or placebo. After 2 weeks, serum 25OHD was significantly higher in the mushroom group than in the placebo group (P=0.001). Serum 25OHD concentrations rose significantly and similarly in the mushroom and supplement groups over the study period by 3.9 nmol/l per week (95% CI: 2.9, 4.8) and 4.7 nmol/l per week (95% CI: 3.8, 5.7), respectively.
Urbain P, Singler F, Ihorst G, et al. Eur J Clin Nutr, 2011. PMID 21540874
2008 / Case report
A case report describes a patient with vitamin D deficiency who rejected standard treatment with a vitamin D-containing calcium supplement. The patient opted to self-treat by consuming UVB-irradiated mushrooms after researching alternative treatment options independently. A beneficial effect of consuming the mushrooms on the patient's plasma biochemical markers was reported.
Shows an association, not proof of cause and effect.
Ozzard A, Hear G, Morrison G, et al. Br J Gen Pract, 2008. PMID 18801283
2013 / Narrative review
This review evaluates the effect of white vegetable consumption (such as potatoes, cauliflowers, turnips, onions, parsnips, white corn, kohlrabi, and mushrooms) on glycemia, satiety, and food intake. The author notes that white vegetables vary widely in their contribution to energy, nutrient content, glycemia, and satiety. Using the potato as an example, the glycemic index can be misleading if not interpreted within the context of total dietary carbohydrate, nutrient composition, and satiety effects in typical meals. The review concludes that applying the glycemic index in isolation to judge white vegetables has led to premature and potentially counterproductive dietary guidance.
Anderson GH, Soeandy CD, Smith CE Adv Nutr, 2013. PMID 23674805
2006 / Narrative review of systematic reviews and clinical experiments
Beta-glucan is a polysaccharide fiber found in grains such as barley, oats, yeast, and mushrooms. The authors reviewed systematic reviews and clinical experiments evaluating the biomedical effects of beta-glucan, including lipid lowering, blood sugar reduction, weight reduction, immune modulation, and anticarcinogenic effects. The review aimed to identify issues and help develop future research strategies.
Kim SY, Song HJ, Lee YY, et al. J Korean Med Sci, 2006. PMID 17043406